CLINICAL_TRIALS
trial_result
· 2021-05-06
Clinical Trial Update: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% [Phase 3]
Summary
Phase 3 trial evaluating ivermectin gel 0.1% plus metronidazole 1% for chronic blepharitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universidad Nacional de Colombia | Conditions: Chronic Blepharitis | Phase 3 | Status: COMPLETED